FibroBiologics, Inc. (FBLG) has disclosed a new risk, in the Corporate Activity and Growth category.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
FibroBiologics, Inc. faces substantial doubt about its ability to continue as a going concern, given recurring operating losses, negative operating cash flows, and reliance on uncertain future financings and collaborations. This doubt could pressure its share price, constrain access to capital, and limit counterparties’ willingness to enter or maintain business relationships, heightening the risk of further program cuts or loss of investor capital.
The average FBLG stock price target is $19.00, implying 1,201.37% upside potential.
To learn more about FibroBiologics, Inc.’s risk factors, click here.